<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="Activity\PMC7703519\results\search\country\results.xml">
  <result pre="highest number of documents issued. This number was driven by" exact="New Zealand" post="and Australia, which respectively constituted 33% and 30% of"/>
  <result pre="constituted 33% and 30% of the documents in the zone." exact="China" post="represented 13% of the total number of documents in"/>
  <result pre="pandemic. To fully benefit from the gains achieved in the" exact="United States" post="of these agile regulatory approaches and extracted lessons for"/>
  <result pre="website]Available at:https://www.fda.gov/patients/fast-track-breakthrough-therapy-accelerated-approval-priority-review/fast-track2018 6collab: Health CanadaPriority review of drug submissions [Health" exact="Canada" post="website]Available at:https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/dhp-mps/alt_formats/hpfb-dgpsa/pdf/prodpharma/prfs_tpfd-eng.pdf2020 7BeningerP.COVID-19: regulatory landscape of medicinal and medical"/>
  <result pre="the management of clinical trials with medicinal drug products in" exact="Switzerland" post="during the COVID-19 pandemic [Swissmedic website]Available at:https://www.swissmedic.ch/dam/swissmedic/fr/dokumente/bewilligungen/klv/swiss_guidance_covid-19.pdf.download.pdf/Swiss_Guidance_COVID-19_v2.0_26.03.2020.pdfJune 15, 2020"/>
  <result pre="during the COVID-19 pandemic: notice to clinical trial sponsors [Health" exact="Canada" post="website]Available at:https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/management-clinical-trials-during-covid-19-pandemic.html2020 21collab: Ministry of Health PharmacyBoardPoisonsGuidance to sponsors"/>
  <result pre="for conduct of clinical trials during the COVID-19 pandemic in" exact="Kenya" post="[Ministry of Health Pharmacy and Poisons Board website]Available at:https://pharmacyboardkenya.org/files/?file=Clinical_Trials_During_COVID-19_Pandemic.pdfApril"/>
  <result pre="the COVID-19 pandemic [European commission website]Available at:https://ec.europa.eu/health/sites/health/files/human-use/docs/guidance_regulatory_covid19_en.pdfApril 10, 2020 28collab:" exact="Australia" post="Therapeutic Goods AdministrationTGA expectations for overseas manufacturing sites hosting"/>
  <result pre="website]Available at:https://www.tga.gov.au/tga-expectations-overseas-manufacturing-sites-hosting-remote-inspections-during-covid-19-pandemicJuly 3, 2020 29collab: National Health Surveillance Agency (Anvisa)," exact="Brazil" post="Ministry of HealthResolution 346: Defines the Extraordinary and Temporary"/>
  <result pre="Medicines Agency [EMA website]Available at:https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/information-note-format-validity-features-electronic-certificates-medicines-issued-european_en.pdfApril 20, 2020 43Ministry of Health" exact="Brazil" post="&amp;amp; AnvisaReolucao de Diretoria colegiada. RDC 355Available at:http://portal.anvisa.gov.br/documents/10181/5815062/RDC_355_2020_COMP.pdf/3b89f5f8-fbfc-43c7-9ff0-3ddc889077baMarch 23,"/>
  <result pre="registration of cosmetics in view of COVID-19 regarding [Government of" exact="India" post="website]Available at:https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTg2OA==April 20, 2020 47collab: Australia Therapeutic Goods AdministrationPhysical"/>
  <result pre="COVID-19 regarding [Government of India website]Available at:https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTg2OA==April 20, 2020 47collab:" exact="Australia" post="Therapeutic Goods AdministrationPhysical samples for batch release not required:"/>
  <result pre="and variation applications during COVID-19 pandemic [Food and drugs authority" exact="Ghana" post="website]Available at:https://fdaghana.gov.gh/img/convid/MEASURES/TAKEN/IN/RELATION/TO/SUBMISSION/OF/APPLICATIONS/DURING/COVID-19--pdfApril 14, 2020 49collab: Organisation for Economic Co-operation"/>
  <result pre="due to COVID-19 [RAPS regulatory focus]Available at:https://www.raps.org/news-and-articles/news-articles/2020/4/european-commission-proposes-to-delay-mdr-by-a-yeaApril 3, 2020 52collab:" exact="Australia" post="Therapeutic Goods AdministrationCOVID-19 delays to adoption of TGO 91"/>
 </snippets>
</snippetsTree>
